Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hemostemix Inc (HEM.VN)

Hemostemix Inc (HEM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hemostemix Inc 707 - 7th Avenue SW Suite 1150 Calgary AB T2P 3H6 CAN

https://www.hemostemix.com P: 905-580-4170

Description:

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

Key Statistics

Overview:

Market Capitalization, $K 3,143
Shares Outstanding, K 89,792
Annual Sales, $ 0 K
Annual Net Income, $ -5,235 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -257 K
60-Month Beta 0.56

Growth:

1-Year Return -78.13%
3-Year Return -86.54%
5-Year Return -97.31%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -66.96%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 12/30/20

HEM.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -338.26%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar